Blood test for early detection of stomach cancer
Part of Cancer, Digestive system clinical trials.
This trial is looking for proteins in the blood that could help find stomach cancer earlier. If you have stomach cancer or are at risk, joining may help improve future diagnosis, and you'll have your blood drawn for testing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 to 95.
- You are in one of these groups: recently diagnosed with stomach cancer (no treatment yet), have precancerous stomach changes, or are healthy with no stomach issues.
- If you have stomach cancer, you must not have received any cancer treatment yet (surgery, chemo, radiation, etc.).
- If you have precancerous changes or are healthy, you have had a biopsy or endoscopy confirming your status.
- You have had no cancer elsewhere and no past cancer treatment.
- You can safely undergo an endoscopy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether a simple blood test can help find stomach cancer early, before symptoms appear. This could offer a less invasive way to detect the disease compared to a scope procedure.
This study looks for a blood “signature” that can spot early, risky stomach changes (before cancer) and stomach cancer. It may help clinicians diagnose earlier and decide who needs closer follow-up.
This study looks for markers in the blood that could show if someone is at risk for stomach cancer or pre-cancerous changes. It aims to help catch problems earlier.
This study looks for marker signals from stomach cancer tissue to improve a detection kit. You may be asked to provide tissue samples, especially if you have a new stomach cancer diagnosis and have not had anti-cancer treatment yet.
This study looks for metabolic markers in your blood and tumor tissue to help find stomach cancer early, predict your prognosis, and watch for recurrence. If you qualify, you would give blood and tumor samples for testing.
This study is testing whether small molecules in your blood (called 'small non-coding RNAs') can help doctors more accurately diagnose stomach cancer. If you have recently been diagnosed, this study will look for those molecules to see if they can be used as a simple blood test in the future.
Hear when a new Gastric Cancer (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.